ImageneBio, Inc. (IMA)

ImageneBio Statistics

Total Valuation

ImageneBio has a market cap or net worth of $59.22 million. The enterprise value is -$55.58 million.

Market Cap	59.22M
Enterprise Value	-55.58M

Important Dates

The last earnings date was Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

ImageneBio has 11.28 million shares outstanding. The number of shares has decreased by -98.35% in one year.

Current Share Class	10.75M
Shares Outstanding	11.28M
Shares Change (YoY)	-98.35%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.48
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.39, with a Debt / Equity ratio of 0.02.

Current Ratio	18.39
Quick Ratio	17.67
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -86.15% and return on invested capital (ROIC) is -53.97%.

Return on Equity (ROE)	-86.15%
Return on Assets (ROA)	-45.61%
Return on Invested Capital (ROIC)	-53.97%
Return on Capital Employed (ROCE)	-41.93%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$3.59M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-340,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	5.60
200-Day Moving Average	7.69
Relative Strength Index (RSI)	41.64
Average Volume (20 Days)	64,732

Short Selling Information

The latest short interest is 470,339, so 4.17% of the outstanding shares have been sold short.

Short Interest	470,339
Short Previous Month	587,281
Short % of Shares Out	4.17%
Short % of Float	n/a
Short Ratio (days to cover)	0.53

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-54.54M
Pretax Income	-50.23M
Net Income	-53.89M
EBITDA	-54.04M
EBIT	-54.54M
Earnings Per Share (EPS)	-$7.06

Balance Sheet

The company has $117.21 million in cash and $2.42 million in debt, with a net cash position of $114.79 million or $10.18 per share.

Cash & Cash Equivalents	117.21M
Total Debt	2.42M
Net Cash	114.79M
Net Cash Per Share	$10.18
Equity (Book Value)	123.33M
Book Value Per Share	10.93
Working Capital	115.37M

Cash Flow

Operating Cash Flow	-55.41M
Capital Expenditures	n/a
Depreciation & Amortization	496,750
Net Borrowing	15.00M
Free Cash Flow	-55.41M
FCF Per Share	-$4.91

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ImageneBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	98.35%
Shareholder Yield	98.35%
Earnings Yield	-91.00%
FCF Yield	-93.58%

Analyst Forecast

The average price target for ImageneBio is $13.00, which is 147.62% higher than the current price. The consensus rating is "Buy".

Price Target	$13.00
Price Target Difference	147.62%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	115.25%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ImageneBio has an Altman Z-Score of 1.43 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.43
Piotroski F-Score	1